# SynOmix Version Comparison: v4.0 â†’ v6.0

## Overview

| Aspect | v4.0 | v6.0 |
|--------|------|------|
| Release Date | Dec 23, 2025 | Dec 25, 2025 |
| Data Layers | 1 (Expression) | 5 (Expression, Mutation, Methylation, CNV, Proteomics) |
| AI Features | None | Streaming Chat + Clinical Insights |
| Cell Analysis | None | Full Deconvolution (10 cell types) |

---

## Feature Comparison

### Data Input

| Feature | v4.0 | v6.0 |
|---------|------|------|
| Gene Expression | âœ… | âœ… |
| Mutations | âŒ | âœ… |
| Methylation | âŒ | âœ… |
| Copy Number | âŒ | âœ… |
| Proteomics | âŒ | âœ… |
| TCGA Format Support | Partial | âœ… Full |
| Compressed Files (.gz) | âŒ | âœ… |

### Analysis Capabilities

| Feature | v4.0 | v6.0 |
|---------|------|------|
| Basic Statistics | âœ… | âœ… |
| Biomarker Detection | Basic | Advanced (49 biomarkers) |
| Multi-omics Integration | âŒ | âœ… |
| Cancer Subtype Prediction | âŒ | âœ… (5 subtypes) |
| Pathway Enrichment | âŒ | âœ… |
| Hypothesis Generation | âŒ | âœ… |
| **Cell-type Deconvolution** | âŒ | âœ… (10 cell types) |
| **Immunotherapy Score** | âŒ | âœ… |

### AI Features

| Feature | v4.0 | v6.0 |
|---------|------|------|
| AI Assistant | âŒ | âœ… |
| Streaming Responses | âŒ | âœ… |
| Context-aware Q&A | âŒ | âœ… |
| Clinical Insights | âŒ | âœ… |

### User Interface

| Feature | v4.0 | v6.0 |
|---------|------|------|
| Dashboard | Basic | Full metrics |
| Results Visualization | Tables | Charts + Cards |
| Export Options | None | PDF |
| Mobile Responsive | âŒ | âœ… |
| Dark Theme | âŒ | âœ… |

---

## New in v6.0: Tumor Microenvironment

The biggest addition in v6.0 is the **Tumor Microenvironment** analysis panel:
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”¬ Tumor Microenvironment           Immunotherapy: 47% â”‚
â”‚                                                         â”‚
â”‚  Tumor Epithelial  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘  16.6%         â”‚
â”‚  CD8+ T Cells      â–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘   7.5%  ğŸŸ¢     â”‚
â”‚  Fibroblasts       â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘  16.2%         â”‚
â”‚  Macrophages       â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  11.2%         â”‚
â”‚  ...                                                    â”‚
â”‚                                                         â”‚
â”‚  ğŸ’¡ Clinical Insights:                                  â”‚
â”‚  âš  Elevated Tregs may indicate immunosuppression       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Cell Types Analyzed
1. Tumor Epithelial
2. CD8+ T Cells (cytotoxic)
3. CD4+ T Cells (helper)
4. Tregs (regulatory)
5. B Cells
6. NK Cells
7. Macrophages
8. Dendritic Cells
9. Fibroblasts
10. Endothelial

### Immunotherapy Prediction
- Score 0-100% based on immune infiltration
- Considers CD8+ T cells, NK cells (positive)
- Considers Tregs, Macrophages (negative/immunosuppressive)

---

## Code Changes Summary

| Metric | v4.0 | v6.0 | Change |
|--------|------|------|--------|
| main.py lines | ~400 | ~900 | +125% |
| index.html lines | ~450 | ~750 | +67% |
| Biomarkers defined | 10 | 49 | +390% |
| Cell signatures | 0 | 10 | New |
| API endpoints | 3 | 8 | +167% |

---

## Migration Notes

### For Users
- No action needed - just refresh the page
- Old uploaded files still work
- Demo data updated with new features

### For Developers
- New dependencies: None (uses existing numpy/pandas)
- New functions: `deconvolve_cell_types()`, streaming chat endpoint
- Breaking changes: None

---

## Performance

| Metric | v4.0 | v6.0 |
|--------|------|------|
| Analysis time (5 layers) | N/A | ~2-3 sec |
| Chat response (perceived) | N/A | Instant (streaming) |
| Memory usage | ~100MB | ~150MB |

---

*Document generated: December 25, 2025*
